SCHEMBL8473511

SCHEMBL8473511

CCCC(=O)c1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1Nc1ccccc1C

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ATP4A P20648 1/20 0.66
▸ ATP4B P51164 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10499040 0.85 ATP4A (0.68) ATP4AATP4B
SCHEMBL9650832 0.85 ATP4A (0.80) ATP4AATP4B
SCHEMBL9260552 0.82 ATP4A (0.76) ATP4AATP4B
SCHEMBL9272700 0.81 ATP4A (0.71) ATP4AATP4B
SCHEMBL9723909 0.81 ATP4A (0.74) ATP4AATP4B
SCHEMBL9349742 0.81 ATP4A (0.74) ATP4AATP4B
SCHEMBL9270832 0.81 ATP4A (0.74) ATP4AATP4B
SCHEMBL9723915 0.80 ATP4A (0.73) ATP4AATP4B
SCHEMBL9723910 0.79 ATP4A (0.78) ATP4AATP4B
SCHEMBL29402089 0.79 ATP4A (1.00) ATP4AATP4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 — — US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 — — EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 — — WO disclosed
Send feedback